Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α - Merx, Kirsten; Müller, Martin Christian; Kreil, Sebastian; Lahaye, T.; Paschka, Peter; Schoch, C.; Weißer, Andreas; Kuhn, C.; Berger, Ute; Gschaidmeier, Harald; Hehlmann, Rüdiger; Hochhaus, Andreas (Leukemia, 2002)
Gesehen am 16.05.2022